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Abstract 
Purpose: To determine the effect of the temperature of water used for the preparation of paracetamol 
and ascorbic acid mixture on its stability, as well as to assess the influence of humidity on the stability of 
single components and their mixtures. 
Methods: The stability of the mixtures in aqueous medium was evaluated with the aid of UV–Vis 
spectrophotometer interfaced with a computer. Spectral analysis was adapted to monitor changes in the 
aqueous medium of a commercial paracetamol and ascorbic acid mixture, an extemporaneously 
prepared mixture of paracetamol and ascorbic acid, and the individual preparations of paracetamol and 
ascorbic acid.  
Results: The degradation rate was lower in commercial preparation (6.80 × 10-3 min-1), compared to 
that of the extemporaneously prepared ascorbic acid/paracetamol mixture (2.30 × 10-2 min-1). The 
decomposition of the commercial product in aqueous medium was 3.38 times slower than that of the 
extemporaneously prepared mixture. Ascorbic acid, tested under the same conditions as the 
commercial product, was unstable in aqueous solutions, with a degradation rate of 1.17×10-2 min-1. 
Ascorbic acid, dissolved in water, degraded completely within 4 h at room temperature, whereas 
paracetamol remained stable under the same conditions for 11 days. 
Conclusion: The individual drugs in their original form retained their stability for 72 h, but some of the 
mixtures, in particular, the extemporaneously prepared ones showed more rapid degradation. 
Extemporaneous preparation of paracetamol/ascorbic acid liquid mixtures should not be encouraged. 
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Among numerous medicinal products from over 
the counter (OTC) class available without a 
medical prescription, there are analgesic and 
antipyretic products. Some of them are available 
in the form of effervescent tablets and powders 
for dissolution in water. If properly stored, 
medicinal products authorised for marketing 
retain their stability during their storage – in the 
manufacturer’s warehouse, pharmacy, or 
patient’s house.  
 
Drug stability is the ability to maintain the 
required characteristics and properties under the 
conditions determined by tests [1]. Usually, it is 
limited to 10 % degradation of an active 
pharmaceutical ingredient (API), that 
manufacturers consider fundamental in 
Shaharuddin et al 
Trop J Pharm Res, August 2015; 14(8): 1316  
 
determining the medicinal product’s expiry date 
[2]. However, the stability of ex tempore 
medicinal products, prepared at home or at the 
patient’s bed, is considerably limited and 
literature sources are often insufficient. Physical 
factors, such as sorption, and water evaporation, 
may adversely affect the drug’s appearance, and 
above all, lead to API degradation, or its irregular 
distribution in the drug form, which negatively 
influences dosing [3,4].  
 
Chemical reactions, such as hydrolysis, oxidation 
and reduction may result in the loss of activity of 
the ingredients, and consequently, hindered 
efficacy or increased toxicity [5]. Information on 
storage and preparation conditions is particularly 
important for patients living in tropical countries 
in III or IV climate zone, where climate conditions 
differ from those of I and II climate zone [6]. 
Paracetamol and ascorbic acid are commonly 
used organic ingredients of OTC medicinal 
products. Paracetamol is a widely used analgesic 
and antipyretic [7,8] while ascorbic acid, due to 
2,3-endiol group in the molecule, may act both as 
an antioxidant or pro-oxidant, depending on the 
concentration [9]. As a result of ascorbic acid 
oxidation to dehydroascorbic acid one hydrogen 
atom is removed and an intermediate product is 
formed – the semi-hydroascorbic radical or two 
hydrogen atoms from the hydroxyl groups 
bonded to the 2nd and 3rd carbon atom [10].  
 
Increased moisture content in commercial 
medicinal powders increases molecular mobility, 
and chemical reactivity [11]. Additionally, 
paracetamol contains the amide group which 
may be sensitive to hydrolytic degradation. 
Research on medicinal products stored in 
different temperatures and humidity has shown 
that physical properties of paracetamol in the 
form of powder and solution remain unaffected 
for even as long as three months [12-14]. It is 
different in the case of ascorbic acid’s stability 
which decreases with increased temperature, 
sun exposure and pH. The dissociation constant 
of the compound is pK = 4.04. The oxidation 
process involves the elimination of two protons at 
pH 1-4 and one proton at pH > 5. With pH 
increasing up to 8.4, dissociation rate remains 
almost constant [15-19]. A higher number of 
ingredients in the product may prevent ascorbate 
from oxidation as a result of oxygen exposure 
[20]. The influence of the preparation conditions 
on the stability of the solutions, prepared by the 
patient at home are of high importance for the 
effectiveness and safety of the therapy [21]. 
 
The aim of this paper was to evaluate the 
stability of ascorbic acid and paracetamol, as 
well as mixtures of them in ambient temperature 
and various humidity conditions, and to 
determine the effect of the temperature of water 
used for the preparation of the solution of 







The commercial mixture of paracetamol and 
ascorbic acid, manufactured by Bristol – Meyers, 
was obtained from the commercial stock of 
commune pharmacy (Fervex D). The 
experiments were conducted with the use P2153 
and P3724 batches. Ascorbic acid was 
purchased from Pharma Cosmetic, Poland. 
Paracetamol of pharmaceutical grade according 





The starting solution was prepared by dissolving 
the contents of one sachet of the product, 
containing 500 mg of paracetamol, 200 mg of 
ascorbic acid, 25 mg of pheniramine maleate, 
and excipients, in a 250 ml volumetric flask. The 
final concentration of ascorbic acid in the starting 
solution was 4.54 × 10-3 mol/l, and that of 
paracetamol was 1.32 × 10-2 mol/l. In order to 
compare the solution of paracetamol and 
ascorbic acid without excipients and additional 
pheniramine maleate, a mixture of those 
substances was prepared in the quantity 
corresponding to the contents of one commercial 
sachet. Parallel individual solutions of ascorbic 
acid and paracetamol, respectively, were 
prepared. The solutions were diluted 100 times 
for the spectrophotometric measurements. Each 
measurement was repeated three times. 
 
Spectrophotometric and potentiometric 
assays 
 
The stability of the paracetamol and ascorbic 
acid mixture in water solutions was evaluated 
with the use of PG Instruments UV – VIS T60 
spectrophotometer (USA) interfaced with the PC 
to enable recording of the results. The pH of the 
starting solutions was measured with the use of 
the Mera Elwro type 517 pH-meter (Poland). 
 
Effect of exposure of aqueous solutions to air 
 
Four starting solutions were tested: solution of 
commercial product, solution of mixture of 
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paracetamol with ascorbic acid, solution of 
paracetamol, solution of ascorbic acid, all of 
them were exposed to air at room temperature 
for eleven days. The air temperature was 25 oC 
and humidity approx. 25 %. The absorbance in 
the 190 - 350 nm range was measured daily at 




To analyse the kinetics of the degradation of the 
paracetamol and ascorbic acid mixture in water, 
the starting solutions were prepared as described 
above. The absorbance was first measured in 
the eleventh minute. Then, the content of API 
was assessed in regular 5-minute intervals until 
the plateau phase was reached. All spectra were 
collected in 190-350 nm range every second, at 
temperature of 25 ˚C. Respective wavelength 
was established due to the literature [22,23]. 
 
Effect of temperature of water on product 
stability 
 
For each type of test samples, five starting 
solutions were prepared with distilled water of the 
following temperature respectively: 8, 25, 30, 50, 
70 and 90 oC. After 60 minutes, the absorbance 
was measured by UV-Vis spectrophotometry at 
190 - 350 nm. 
 
Effect of humidity on the stability of ascorbic 
acid  
 
The tests were conducted with the use of 
following powders: (1) a commercial mixture of 
paracetamol and ascorbic acid, with pheniramine 
maleate added, available in Polish pharmacies, 
(2) ascorbic acid, (3) mixture of ascorbic acid and 
paracetamol prepared in the laboratory in the 
form of powder. The effect of humidity on stability 
of assessed powders was tested using eight 
samples of powder, reflecting 80 mg of API – 
ascorbic acid. Four of them were placed in open 
weighing bottles, exposed to air, at room 
temperature, while the other four were placed in 
a desiccator containing hydrophilic silica, and 
incubated in the period 1 – 72 h. After 1, 2, 3, 24, 
48, and 72 h the samples were weighed and 
used to prepare solutions. The absorbance of 





The analysis of the data obtained was conducted 
with a Statistica 10.0 software. The Wilcoxon test 
was performed, d < 0.05. The kinetic degradation 
rate constants were evaluated as a function y = 





Effect of storage time on the stability of the 
mixture of paracetamol and ascorbic acid in 
water  
 
Changes in the aqueous solutions of the 
commercial paracetamol and ascorbic acid 
mixture (A), mixture of paracetamol and ascorbic 
acid (B), paracetamol (C) and ascorbic acid (D) 
were monitored spectrophotometrically and the 
results are shown in Fig 1. 
 
The results obtained for the solutions of 
commercial mixture and the prepared mixture are 
similar (Fig 1A and B). After one day, ascorbic 
acid in both solutions degraded and only 
paracetamol remained unchanged (Fig 1C), 
whereas in the case of ascorbic acid, 
degradation was very rapid (Fig 1D). In the 
analysis of the effect of storage time on the 
stability of paracetamol in water solution for 11 
days, the absorbance remained largely the 
same, and the spectral shape did not change, 
which proves that the paracetamol solution was 
stable in that period of time. The difference 
between the level of the paracetamol solution 
absorbance measured on the last day (day 11), 
and the absorbance obtained on the 1st day was 
below 5 % (p < 0.05, Wilcoxon test) showed that 
those differences were not statistically significant.  
 
Degradation of paracetamol and ascorbic 
acid in aqueous solution 
 
Based on Fig 2A, the maximum absorbance at 
the fixed wavelength, decreases with time. The 
decrease is very fast, both in the case of the 
paracetamol and ascorbic acid solution, as well 
as in the case of Fervex D. Initially the 
absorbance decreases rapidly, while after a 
longer time, it enters into the plateau phase. To 
compare the kinetics of the degradation process 
in aqueous solution of both samples, the function 
graph, y = A1 + A0e-kt, was estimated using 
Gauss–Newton algorithm. The slopes of the 
straight lines reflect the variability of the 
degradation processes. The degradation rate 
was lower for the commercial preparation (6.80 × 
10-3 min-1), than the extemporaneously prepared 
mixture of ascorbic acid and paracetamol (2.30 × 
10-2 min-1). The degradation of commercial 
product in the water solution was 3,38 times 
slower than the degradation of the 
extemporaneously prepared mixture of ascorbic  
Shaharuddin et al 

































































Fig 1: UV-VIS spectra of the solutions of: commercial 
paracetamol and ascorbic acid mixture (A), mixture of 
paracetamol and ascorbic acid (B), paracetamol (C), 
ascorbic acid (D) recorded every 24 hours for 11 days. 
The thin line (-) represents the absorbance at the initial 
stage, whereas the thick line (▬) represents the 
absorbance after 11 days 
 
Fig 2: (A) Changes of absorbance vs. time, of the 
commercial product solution, thin line (-) and the “in-
house” prepared paracetamol and ascorbic acid 
solution, dotted line (--) measured at the maximum 
signal, 256 nm wavelength, and time, presented as a 
function  y=A1+A0e-kt estimated with the use of the 
Gauss–Newton algorithm. (B) Correlation of the 
absorbance of the ascorbic acid solution and time 
measured at the 256 nm wavelength, presented as a 
function, y=A1+A0e-kt, estimated with the use of the 
Gauss–Newton algorithm 
 
acid and paracetamol . Ascorbic acid, tested 
under same conditions as the commercial 
product was unstable, with a degradation rate of 
1.17 × 10-2 min-1. 
 
Effect of the temperature of water used on 
stability of ingredients 
 
According to the results, the temperature of 
water used for preparation of the solutions has 
no significant effect on the stability of ascorbic 
acid, paracetamol and their mixture produced in 
laboratory. Almost 18 % increase in absorbance 
was observed in the case of the solutions of 
commercial mixtures prepared at extreme 
temperatures: 8 oC and 90 oC, whereas in the 
case of intermediate temperatures of 25, 35, 50 
and 70 oC the values of the absorbance were 
lower. Differences between the maximum 
absorbance values were < 5 %, and statistically 
not significant for the temperature range 25 – 70 
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°C. The influence of temperature on the 
assessed absorbance in the case of the 
commercial mixture of ascorbic acid and 
paracetamol is presented in Fig 3. 
 
 
Fig 3: Influence of temperature of used water on the 
absorbance of the solutions of commercial mixture 
(paracetamol + ascorbic acid) at maximum wavelength 
of 256 nm 
 
Effect of humidity on stability of paracetamol 
and ascorbic acid mixture 
 
The absorbance value of the maximal signal for: 
the individual solutions of ascorbic acid, 
paracetamol, mixture of both ascorbic acid and 
paracetamol, as well as commercial mixtures 
remained at a constant level for 4 consecutive 
days. The maximal absorbance of the solution of 
paracetamol alone was approximately 0.3154, 
whereas the other solutions maintained their 
absorbance at 0.6219, 0.5958 and 0.4771 for 
commercial formulation, extemporaneously 
prepared mixture, and ascorbic acid, 
respectively. Variation in maximal absorbance 
and weight of sample in the test period was 





Based on the results obtained, degradation was 
retarded in the commercial mixture of 
paracetamol and ascorbic acid, compared to the 
solution of ascorbic acid and paracetamol without 
excipients. Due to the high instability in water 
solution, the ascorbic acid, when evaluated as 
single component of the solution, degraded 
completely after ca. 250 min of the initiation of 
the reaction. Degradation of ascorbic acid in the 
solution of commercial product proceeded slowly. 
Conversely, the ascorbic acid in the mixture of 
paracetamol and ascorbic acid, as well as the 
solution of ascorbic acid itself degraded rather 
fast. Ascorbic acid contains a dienol group with 
strong reducing activity, which leads to the fast 
degradation of the structure. The product of its 
oxidation is dehydroascorbic acid which is even 
less stable. The stability of the commercial 
mixture of paracetamol and ascorbic acid in the 
solution was enhanced due to the excipients 
contained in the pharmaceutical product, such as 
citric acid and magnesium citrate, stabilizers of 
the ascorbic acid [24]. Citric buffer, which is 
formed in situ after dissolution of the commercial 
product, ensures the optimal pH of the water 
solution, which was ca. 4.8 in the performed 
measurements. The increased pH results in 
prolonged degradation of ascorbic acid in the 
aqueous solution, comparing to the solution of 
mixture of ascorbic and paracetamol prepared in 
laboratory, with a pH of 3.7. The absorbance of 
the solution of paracetamol remained at the 
same level for 450 min, which supports the idea 
of stability of paracetamol under the test 
conditions, in the absence of ascorbic acid.  
 
It can be assumed that even water evaporation, 
which might have occurred during the test, did 
not affect significantly the stability of the 
assessed single/individual substances, but for 
the mixture of ascorbic acid and paracetamol in 
the commercial product, the temperature of the 
water influenced the content of ascorbic acid. 
The obtained results correspond to the 
recommendations of the pharmaceutical 
product’s manufacturer in the product leaflet: 
“dissolve the content of the sachet in cold or hot 
water”. According to the European 
Pharmacopoeia, “cold” water temperature ranges 
8 – 15 oC, while “hot” water is at least 80 oC. 
Polyvinyl pyrrolidone (PVP), as an excipient may 
influence the amount of drug in solution. The 
increased temperature of the solution favours 
decrease of PVP chain length, as well as 
decrease of the viscosity [25]. This may 
contribute directly to the decrease in the number 
of hydrogen bonds between polymer molecules 
and drug molecules, which may then result in 
decreased solubility of the drug [26]. Therefore 
increased absorbance may be observed in the 
commercial mixture prepared in water at 8 oC, 
compared to other temperatures.  
 
PVP may increase the solubility of paracetamol, 
as is the case for other active substances, by 
forming easily soluble complexes [27,28]. There 
is a correlation between the increase in solubility 
of paracetamol in water solution, and the 
increase in the number of hydrogen bonds 
between polymer hydroxyl groups and 
paracetamol carboxyl groups confirmed [29]. 
Polymer-solvent interactions depend upon the 
polymer molecular structure, chemical 
composition, solution concentration, solvent 
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molecular structure, and solution temperature. As 
temperature rises, the entropy of the system 
increases, which may contribute to the formation 
of intercyclic and intracyclic reactions. Also 
intermolecular hydrogen bonds may appear, 
resulting in the increased UV absorbance at 90 
oC. Previous tests did not reveal any effect of 
evaporation on the results. 
 
Air humidity did not exert any effect on the 
stability of ascorbic acid, paracetamol and 
mixtures of ascorbic acid and paracetamol, 
whether commercial and extemporaneously 
prepared. Based on literature, the weight of 
vitamin C remains the same for 8 weeks when 
exposed to an atmosphere of 0 and 75 % relative 
humidity at room temperature [30]. In another 
study, under normal storage conditions, 
commercial tablets of ascorbic acid were stable 




The findings of this study indicate that the 
conditions of preparation, viz, temperature of 
water, amount of active ingredient in the aqueous 
commercial mixture of ascorbic acid and 
paracetamol did not affect product stability. 
Ascorbic acid in aqueous solution degrades 
completely within 4 h at room temperature, 
whereas paracetamol remains stable under the 
same conditions for 11 days. Relative humidity 
under the test conditions does not affect 
significantly the stability of individual 
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